These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36792176)

  • 41. Prevalence of growth hormone (GH) deficiency in previously GH-treated young adults with Prader-Willi syndrome.
    Donze SH; Damen L; van Alfen-van der Velden JAEM; Bocca G; Finken MJJ; Hoorweg-Nijman GJG; Jira PE; van Leeuwen M; Hokken-Koelega ACS
    Clin Endocrinol (Oxf); 2019 Jul; 91(1):118-123. PubMed ID: 30973645
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prader-Willi Syndrome in Adults: An Update On Nutritional Treatment and Pharmacological Approach.
    Barrea L; Vetrani C; Fintini D; de Alteriis G; Panfili FM; Bocchini S; Verde L; Colao A; Savastano S; Muscogiuri G
    Curr Obes Rep; 2022 Dec; 11(4):263-276. PubMed ID: 36063285
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Benefits of multidisciplinary care in Prader-Willi syndrome.
    Salvatoni A; Nosetti L; Salvatore S; Agosti M
    Expert Rev Endocrinol Metab; 2021 Mar; 16(2):63-71. PubMed ID: 33724138
    [No Abstract]   [Full Text] [Related]  

  • 44. What is the value of growth hormone therapy in Prader Willi syndrome?
    Bridges N
    Arch Dis Child; 2014 Feb; 99(2):166-70. PubMed ID: 24162007
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Disorders of glucose metabolism in Prader-Willi syndrome: Results of a multicenter Italian cohort study.
    Fintini D; Grugni G; Bocchini S; Brufani C; Di Candia S; Corrias A; Delvecchio M; Salvatoni A; Ragusa L; Greggio N; Franzese A; Scarano E; Trifirò G; Mazzanti L; Chiumello G; Cappa M; Crinò A;
    Nutr Metab Cardiovasc Dis; 2016 Sep; 26(9):842-7. PubMed ID: 27381990
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The GHRH + arginine stimulated pituitary GH secretion in children and adults with Prader-Willi syndrome shows age- and BMI-dependent and genotype-related differences.
    Marostica E; Grugni G; De Nicolao G; Marazzi N; Crinò A; Cappa M; Sartorio A
    Growth Horm IGF Res; 2013 Dec; 23(6):261-6. PubMed ID: 24090687
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exacerbation of BMI after cessation of growth hormone therapy in patients with Prader-Willi syndrome.
    Oto Y; Tanaka Y; Abe Y; Obata K; Tsuchiya T; Yoshino A; Murakami N; Nagai T
    Am J Med Genet A; 2014 Mar; 164A(3):671-5. PubMed ID: 24443368
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Psychiatric behavioral effect and characteristics of type 2 diabetes mellitus on Japanese patients with Prader-Willi syndrome: a preliminary retrospective study.
    Oto Y; Murakami N; Inoue T; Matsubara K; Saima S; Ogata H; Ihara H; Nagai T; Matsubara T
    J Pediatr Endocrinol Metab; 2022 Jan; 35(1):89-96. PubMed ID: 34792304
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reduced growth hormone (GH) responsiveness to combined GH-releasing hormone and pyridostigmine administration in the Prader-Willi syndrome.
    Grugni G; Guzzaloni G; Moro D; Bettio D; De Medici C; Morabito F
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):769-75. PubMed ID: 9713567
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The use of medical care and the prevalence of serious illness in an adult Prader-Willi syndrome cohort.
    Sinnema M; Maaskant MA; van Schrojenstein Lantman-de Valk HM; Boer H; Curfs LM; Schrander-Stumpel CT
    Eur J Med Genet; 2013 Aug; 56(8):397-403. PubMed ID: 23792791
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence for Accelerated Biological Aging in Young Adults with Prader-Willi Syndrome.
    Donze SH; Codd V; Damen L; Goedegebuure WJ; Denniff M; Samani NJ; van der Velden JAEM; Hokken-Koelega ACS
    J Clin Endocrinol Metab; 2020 Jun; 105(6):2053-9. PubMed ID: 31689713
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Beneficial Effects of GH in Young Adults With Prader-Willi Syndrome: A 2-Year Crossover Trial.
    Kuppens RJ; Bakker NE; Siemensma EP; Tummers-de Lind van Wijngaarden RF; Donze SH; Festen DA; van Alfen-van der Velden JA; Stijnen T; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4110-4116. PubMed ID: 27552545
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Italian National Survey for Prader-Willi syndrome: an epidemiologic study.
    Grugni G; Crinò A; Bosio L; Corrias A; Cuttini M; De Toni T; Di Battista E; Franzese A; Gargantini L; Greggio N; Iughetti L; Livieri C; Naselli A; Pagano C; Pozzan G; Ragusa L; Salvatoni A; Trifirò G; Beccaria L; Bellizzi M; Bellone J; Brunani A; Cappa M; Caselli G; Cerioni V; Delvecchio M; Giardino D; Iannì F; Memo L; Pilotta A; Pomara C; Radetti G; Sacco M; Sanzari A; Sartorio A; Tonini G; Vettor R; Zaglia F; Chiumello G;
    Am J Med Genet A; 2008 Apr; 146A(7):861-72. PubMed ID: 18203198
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cross-cultural comparisons of obesity and growth in Prader-Willi syndrome.
    Dudley O; McManus B; Vogels A; Whittington J; Muscatelli F
    J Intellect Disabil Res; 2008 May; 52(Pt 5):426-36. PubMed ID: 18298478
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metabolic syndrome in adult patients with Prader-Willi syndrome.
    Grugni G; Crinò A; Bedogni G; Cappa M; Sartorio A; Corrias A; Di Candia S; Gargantini L; Iughetti L; Pagano C; Ragusa L; Salvatoni A; Spera S; Vettor R; Chiumello G; Brambilla P
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1134-40. PubMed ID: 23220075
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Medical, psychological and social features in a large cohort of adults with Prader-Willi syndrome: experience from a dedicated centre in France.
    Laurier V; Lapeyrade A; Copet P; Demeer G; Silvie M; Bieth E; Coupaye M; Poitou C; Lorenzini F; Labrousse F; Molinas C; Tauber M; Thuilleaux D; Jauregi J
    J Intellect Disabil Res; 2015 May; 59(5):411-21. PubMed ID: 24947991
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prader-Willi syndrome and growth hormone deficiency.
    Aycan Z; Baş VN
    J Clin Res Pediatr Endocrinol; 2014; 6(2):62-7. PubMed ID: 24932597
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment.
    Höybye C
    Growth Horm IGF Res; 2004 Feb; 14(1):1-15. PubMed ID: 14700552
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impairment of GH responsiveness to combined GH-releasing hormone and arginine administration in adult patients with Prader-Willi syndrome.
    Grugni G; Marzullo P; Ragusa L; Sartorio A; Trifirò G; Liuzzi A; Crinò A;
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):492-9. PubMed ID: 16984242
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Growth hormone therapy for Prader-Willi syndrome: a critical appraisal.
    Allen DB; Carrel AL
    J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1297-306. PubMed ID: 15506076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.